Estimation of complement C3 in oral submucous fibrosisBORLE, R. M; JAGTAP, M. W.International journal of oral and maxillofacial surgery. 1987, Vol 16, Num 6, pp 753-756, issn 0901-5027Article

GINGIVAL FLUID ANS SERUM IN PERIODANTAL DISEASES. II. EVIDENCE FOR CLEAVAGE OF COMPLEMENT COMPONENTS C₃, C₃ PROACTIVATOR (FACTOR B) AND C₄ IN GINGIVAL FLUID.SCHENKEIN HA; GENCO RJ.1977; J. PERIODONTOL.; U.S.A.; DA. 1977; VOL. 48; NO 12; PP. 778-784; BIBL. 34 REF.Article

A CASE OF COXSACKIE A9 VIRUS INFECTION WITH ORCHITISWILLEMS WR; HORNIG C; BAUER H et al.1978; J. MED. VIROL.; USA; DA. 1978; VOL. 3; NO 2; PP. 137-140; BIBL. 8 REF.Article

SERUM IMMUNOGLOBULINS AND COMPLEMENT (C'3) IN ORAL LICHEN PLANUSSKLAVOUNOU AD; LASKARIS G; ANGELOPOULOS AP et al.1983; ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY; ISSN 0030-4220; USA; DA. 1983; VOL. 55; NO 1; PP. 47-51; BIBL. 18 REF.Article

DEPOSITS OF IMMUNOGLOBULIN G AND COMPLEMENT C3 IN RECURRENT APHTHOUS ULCERATIONS.DONATSKY O; DABELSTEEN E.1977; SCAND. J. DENT. RES.; DENM.; DA. 1977; VOL. 85; NO 6; PP. 419-425; BIBL. 14 REF.Article

Internalization of Coxsackievirus A9 Is Mediated by β2-Microglobulin, Dynamin, and Arf6 but Not by Caveolin-1 or ClathrinHEIKKILÄ, Outi; SUSI, Petri; TEVALUOTO, Tuire et al.Journal of virology. 2010, Vol 84, Num 7, pp 3666-3681, issn 0022-538X, 16 p.Article

Preliminary crystallographic analysis of coxsackievirus A9SMYTH, M; HALL, J; FRY, E et al.Journal of molecular biology. 1993, Vol 230, Num 2, pp 667-669, issn 0022-2836Article

A novel indole-3-carbinol derivative inhibits the growth of human oral squamous cell carcinoma in vitroWENG, Jing-Ru; BAI, Li-Yuan; OMAR, Hany A et al.Oral oncology (1997). 2010, Vol 46, Num 10, pp 748-754, issn 1368-8375, 7 p.Article

Molecular characterization of complement components (C3, C4, and factor B) in human salivaANDOH, A; FUJIYAMA, Y; KIMURA, T et al.Journal of clinical immunology. 1997, Vol 17, Num 5, pp 404-407, issn 0271-9142Article

Integrin αVβ6 is a high-affinity receptor for coxsackievirus A9HEIKKILÄ, Outi; SUSI, Petri; STANWAY, Glyn et al.Journal of general virology. 2009, Vol 90, pp 197-204, issn 0022-1317, 8 p., 1Article

Factors affecting virus plaque confirmation proceduresDAHLING, D. R; SULLIVAN, G; FREYBERG, R. W et al.Journal of virological methods. 1989, Vol 24, Num 1-2, pp 111-122, issn 0166-0934Article

Efficient RGD-independent entry process of coxsackievirus A9ROIVAINEN, M; PIIRAINEN, L; HOVI, T et al.Archives of virology. 1996, Vol 141, Num 10, pp 1909-1919, issn 0304-8608Article

Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breastVIJAYAKUMAR, T; RAVINDRAN ANKATHIL; REMANI, P et al.Journal of clinical immunology. 1987, Vol 7, Num 4, pp 300-303, issn 0271-9142Article

LUPUS BAND TEST IN UNINVOLVED ORAL MUCOSA IN SYSTEMIC LUPUS ERYTHEMATOSUSJONSSON R; NYBERG G; KRISTENSSON AAS A et al.1983; ACTA MEDICA SCANDINAVICA; ISSN 0001-6101; SWE; DA. 1983; VOL. 213; NO 4; PP. 269-273; BIBL. 19 REF.Article

A combined method for rescue of modified enteroviruses by mutagenic primers, long PCR and T7 RNA polymerase-driven in vivo transcriptionHEIKKILÄ, Outi; KAINULAINEN, Markus; SUSI, Petri et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 129-133, issn 0166-0934, 5 p.Article

Disseminated coxsackie A9 infection complicating bone marrow transplantationAQUINO, V. M; FARAH, R. A; LEE, M. C et al.The Pediatric infectious disease journal. 1996, Vol 15, Num 11, pp 1053-1054, issn 0891-3668Article

FREISETZUNG ZELLULAERER ENZYME WAEHREND DER VERMEHRUNG VON COXSACKIEVIRUS A9 IN FL-ZELLEN. II.ABHAENGIGKEIT DER ENZYMFREISETZUNG VON ZELLDICHTE, VIRUSKONZENTRATION, PH-WERT UND SERUMGEHALT DES INKUBATIONSMEDIUMS = LIBERATION DE L'ENZYME CELLULAIRE AU COURS DE LA MULTIPLICATION DU COXSACKIEVIRUS A9 EN CELLULES FL. II.INFLUENCE DU NOMBRE DE CELLULES, DE LA CONCENTRATION DE VIRUS, DU PH ET DE LA TENEUR EN SERUM DU MILIEU DE CULTURE SUR CETTE LIBERATIONKLOCKING R; SCHWEIZER H; SPROSSIG M et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 3-4; PP. 353-359; ABS. ANGL.; BIBL. 10REF.Article

A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virionsROIVAINEN, Merja; ALAKULPPI, Noora; YLIPAASTO, Petri et al.Journal of virological methods. 2005, Vol 130, Num 1-2, pp 108-116, issn 0166-0934, 9 p.Article

Photoinactivation of three viruses by rose bengalLEWIS, A. L; WELLINGS, F. M; MARTIN, D. F et al.Journal of environmental science and health. Part A, Environmental science and engineering. 1988, Vol 23, Num 2, pp 127-137, issn 0360-1226Article

Coxsackie A-9 in the etiology of poliomyelitis-like diseasesSANTHANAM, S; CHOUDHURY, D. S.Indian journal of pediatrics. 1985, Vol 52, Num 417, pp 405-408, issn 0019-5456Article

ORAL LESIONS OF EPIDERMOLYSIS BULLOSA ACQUISITA.NILSEN R; LIVDEN J; THUNOLD S et al.1978; ORAL SURG. ORAL MED. ORAL PATHOL.; U.S.A.; DA. 1978; VOL. 45; NO 5; PP. 749-754; BIBL. 14 REF.Article

Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptorRAMANATHAN, Murugappan; SPANNHAKE, Ernst W; LANE, Andrew P et al.The Laryngoscope. 2007, Vol 117, Num 10, pp 1839-1843, issn 0023-852X, 5 p.Article

STUDIES ON THE INTERACTION BETWEEN COXSACKIEVIRUS A9 AND HELA CELLS. I. PLAQUE-FORMING ABILITY OF COXSACKIEVIRUS A9 IN HELA CELL CULTURES.MATSUMOTO M; NAKANO M; NISHIKAWA F et al.1976; JAP. J. MED. SCI. BIOL.; JAP.; DA. 1976; VOL. 29; NO 2; PP. 67-76; BIBL. 15 REF.Article

A novel one-step oxidation of terminal epoxides to allylic aldehydesWILLIS, C. L.Tetrahedron letters. 1987, Vol 28, Num 19, pp 2175-2178, issn 0040-4039Article

Involvement of the IL-22/REG Iα axis in ulcerative colitisSEKIKAWA, Akira; FUKUI, Hirokazu; FUJIMORI, Takahiro et al.Laboratory investigation. 2010, Vol 90, Num 3, pp 496-505, issn 0023-6837, 10 p.Article